(Q83380976)
Statements
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner (English)
Andrea Mencarelli
Daniela Francisci
Barbara Renga
Sabrina Cipriani
Flavia Basile
Elisabetta Schiaroli
Franco Baldelli
Stefano Fiorucci